For the better understanding of engraftment properties after autologous peripheral blood stem cell transplantation (PBSCT), hematopoietic recovery, immune reconstitution and functional capacity of cytokine production in different lymphocyte populations were examined. In a prospective study, we examined 24 patients suffering from different malignancies after autologous PBSCT. 
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Autologous peripheral blood stem cell transplantation (PBSCT) has become an established treatment modality for patients with advanced hematological malignancies partly replacing bone marrow transplantation (BMT).
1-5 G-CSFmobilized peripheral blood stem cells (PBSCs) are becoming an attractive alternative to bone marrow as a stem cell source. The advantages include shortening of severe neutropenia, and lower rate of life-threatening complications. Using PBSCT an absolute neutrophil count Ͼ0.5 × 10 9 /l is reached on days 9-11 and platelet transfusion independence with platelet counts Ͼ20 × 10 9 /l on days 12-16. [6] [7] [8] [9] [10] [11] [12] [13] [14] More recently, conflicting data about immune reconstitution after autologous or allogeneic PBSCT/BMT were published regarding the distinct regeneration kinetics of T and B cells. [15] [16] [17] [18] To date, little is known about immune competence and functional integrity of the cellular immune system regenerated after autologous PBSCT.
In the present study, we prospectively evaluated the immune reconstitution of lymphocyte populations such as B, T, and natural killer (NK) cells in 24 patients undergoing PBSCT. In addition, we analyzed the production of interferon gamma (IFN␥), interleukin (IL-)2, IL-4 and tumor necrosis factor alpha (TNF␣) in CD3 + CD4 + helper/inducer T cells and CD3 + CD8 + suppressor/cytotoxic T cells using multi-parameter flow cytometry that allows simultaneous intracellular staining of cytokines and phenotyping of surface antigens.
Materials and methods

Patients
In our study we initially enrolled 24 adult patients (12 male/12 female) with a mean age of 51 (25 to 65 years), one excluded due to early death (number of patients after the first month n = 24, after 3 months n = 21, 6 months n = 17, 12 months n = 16). With respect to their underlying diseases, the patients underwent different myeloablative high-dose chemotherapy (HDC) regimens followed by autologous PBSCT (Table 1) . In all cases G-CSF (ෂ5 g/kg/day) was administered after PBSCT. On average, 4.33 Ϯ 1.86 ϫ 10 6 CD34 + cells/kg BW collected with 1.88 Ϯ 0.67 (range 1-3) leukaphereses were transplanted. In the case of multiple myeloma, patients received interferon alpha (3 MU three times a week) weekly after PBSCT. Patients with non-metastatic breast cancer were treated with radiation therapy to the chest wall, axillar, supraclavicular area and the internal mammary nodes. No other treatment was started within 1 year of examination.
Hematological analysis
Blood samples were obtained 1, 3, 6 and 12 months post PBSCT. A three-part differential was performed by using a Coulter Counter STKS (Beckman Coulter, Krefeld, Germany) according to the manufacturer's instructions.
Immune phenotyping
Lymphocyte subsets were monitored by using flow cytometry. All analyses were performed on an EPICS XL MCL (Beckman Coulter) equipped with a single air-cooled argon laser (488 nm) and System II software version 2.1 was used for data aquisition. The flow cytometer was adjusted according to the manufacturer's instructions. One hundred l blood was incubated with fluorochrome-conjugated (FITC/PE) primary antibodies for 15 min at RT in the dark. Anti-CD3, anti-CD4, anti-CD8, anti-CD45RA/R0 antibodies were used for T lymphocyte phenotyping, anti-CD19 for B lymphocytes and anti-CD16/56 for NK cells.
Background fluorescence was determined with appropriate isotype-specific controls. Red blood cells were lysed by acetic acid followed by a mild paraformaldehyde (PFA) fixation (Qprep workstation; Beckman Coulter). Lymphocytes were gated using linear forward and side scatters to exclude non-lysed erythrocytes and cell debris. The following antibodies, CD45RA-PE/CD4-FITC, CD45RA-PE/CD8-FITC, CD45RO-PE/CD8-FITC, CD45RO-PE/CD4-FITC were purchased from PharMingen (Hamburg, Germany) and used in a concentration of 20 l, whereas all other antibodies were purchased from Beckman Coulter and used in a concentration of 10 l.
Detection of intracellular cytokines
The production of T lymphocyte-specific cytokines was evaluated in 10 patients by intracellular staining on single-cell level using multi-color flow cytometry. 19, 20 In addition to the percentage of cytokine-producting cells the mean fluorescence intensity (MFI) shift of cytokine-producing and cytokine non-producing cells was calculated. Briefly, after isolation of Ficolled MNCs, cells were resuspended in RPMI 1640 (1 ϫ 10 6 cells/ml) and stimulated with 10 ng/ml phorbol-12-mystrate-13-acetate (PMA; Sigma, Deisenhofen, Germany) and 1 m ionomycin (Sigma) for 5 h. Monensin (2.5 m; Sigma) was added in order to promote the accumulation of de novo synthesized cytokines in the Golgi apparatus. Cells were washed and fixed at 4°C in HBSS containing 4% PFA (Riedel-de Haen, Seelze, Germany) for 10 min. Cells were washed, resuspended in saponin-buffer for permeabilization (HBSS containing 0.1% saponin and 0.01 m Hepes buffer) (Seromed Biochrome, Berlin, Germany) and simultaneously stained with directly fluorochrome-conjugated cytokine and surface marker antibodies. For the detection of surface epitopes we used anti-CD3-Cy5, anti-CD8-FITC and monoclonal antibodies for IL-2, IL-4,IL 5, IL-10, IFN␥ and TNF␣ (PharMingen).
Statistical analysis
Statistical analysis was performed with commercially available software (Sigma Plot). Data are expressed as mean Ϯ s.d. if not otherwise stated. For data comparing patients and normals we used the unpaired Student's t-test after confirming the parametric distribution of the KS test.
Results
Hematological recovery
Hematopoiesis engrafted after HDC followed by PBSCT with absolute neutrophil counts Ͼ0.5 ϫ 10 9 /l on day 10 Ϯ 1 (range [8] [9] [10] [11] [12] and platelet transfusion independence with platelets Ͼ20 ϫ 10 9 /l on day 13 Ϯ 3 (range 7-18). WBCs of 5510 Ϯ 589/l decreased to 4100 Ϯ 243/l after 12 months (data not shown). After 1 month, the slight monocytosis (15.7 Ϯ 1.1%) disappeared. Granulocyte and lymphocyte counts remained stable at 60.2 Ϯ 3.3% and 21.1 Ϯ 2.9% 1 month vs 59.4 Ϯ 2.5% and 27.6 Ϯ 2.6% 12 months post PBSCT (data not shown). One month after PBSCT the mean hemoglobin value was 11.1 Ϯ 0.3 g/dl and showed an increase to 12.0 Ϯ 0.4 g/dl in the 12th month. The short-term engraftment of megakaryocytes resulted in platelet counts of 149 Ϯ 20/nl dropping moderately to a 12 month value of 119 Ϯ 12/nl.
Immune reconstitution
We observed a prompt recovery of NK cells, which achieved normal counts 1 month post PBSCT (236 Ϯ 39/l) reflecting a relative NK lymphocytosis (23.7 Ϯ 2.8%) (Figure 1 ). After 12 months the NK cell levels stabilized to a lower level (14.3 Ϯ 2.1%, 153 Ϯ 20/l). In contrast, B lymphopoiesis was severely depressed. One month post PBSCT, no significant B cell regeneration was detectable (0.9 Ϯ 0.2%), in the following months the B cells reconsti- 
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+ suppressor/cytotoxic T cells (331 Ϯ 94/l) at the first time interval investigated, and remained stable over 12 months (279 Ϯ 57/l), whereas a durable depression of the CD3 + CD4 + inducer/helper T cell subpopulation was detected (121 Ϯ 18/l at 1 month vs 174 Ϯ 33/l at 12 months). This phenomenon is reflected by an inversion of the CD4/CD8 ratio. Furthermore, 1 year post PBSCT the naive CD4 + CD45RA + was markedly depressed to 4.3-7.0%.
Measurement of intracellular cytokines in T lymphocytes
We evaluated the production of T cell cytokines like IL-2, IL-4, IL-5, IL-10, IFN␥ and TNF␣ by flow cytometry (Figure 2 ). The production of IL-4, IL-5 and IL-10 primarily synthesized by CD3 + T lymphocytes is limited on a level Ͻ2% using PMA/ionomycin stimulation for 5 h (data not shown). The IFN␥ production of CD3 + T cells in patients 1 month after PBSCT (16.4 Ϯ 3.3%, P = 0.05) was significantly lower compared to healthy volunteers (25.2 Ϯ 1.9%) and stabilized to 31.0 Ϯ 5.7% (P = 0.26) after 12 months The analysis of T lymphocyte subset populations showed a high cytokine production by CD8 + T cells with 22.6 Ϯ 4.7% (MFI shift: 12.3 Ϯ 3.4) after 1 and 34.9 Ϯ 5.9% (MFI shift: 21.6 Ϯ 3.1) after 12 months whereas the CD8 − population remained low (12.6 Ϯ 3.1 % (MFI shift: 12.4 Ϯ 2.4) after 1 and 20.8 Ϯ 4.3% (MFI shift: 18.7 Ϯ 2.6) after 12 months). After PBSCT, TNF␣ levels (1 month: 24.9 Ϯ 4.0%, P = 0.05, 12 months: 31.6 Ϯ 4.8%, P Ͻ 0.001) were significantly elevated compared to the control group (18.7 Ϯ 1.2%). In detail, the CD8 + subpopulation started with 21.8 
Discussion
Following HDC, the restoration to all levels of the hematopoietic hierachy is thought to be based on regenerative potential of pluripotent HSCs transfused within the graft. [6] [7] [8] [9] In the past, the rapid and sustained engraftment of bone marrow was empirically correlated with the total number of nucleated cells transfused. 1, 4 There is accumulating evidence for the predictive power of CD34 + cell concentration per kg body weight (BW) leading to sufficient engraftment. 2, 3 The threshold of 2 ϫ 10 6 CD34 + cells/kg BW is established. Increasing stem cell dosages are correlated with an accelerated speed of hematopoietic reconstitution. 12, 21 In our study, all patients showed a regular and rapid short-term recovery of hematopoiesis after a short period of severe neutro-and thrombocytopenia. The data confirms that, after PBSCT, hematopoietic reconstitution occurs after an interval of about 2 weeks, showing more advantages compared with BMT. 15, 16, 18 The hematopoietic reconsti- Bone Marrow Transplantation tution pattern might suggest that the initial engraftment is mediated by more lineage-committed progenitors, while pluripotent HSCs are responsible for the final maintenance of hematopoiesis. [21] [22] [23] [24] [25] In contrast, there are convincing data indicating that early HSCs are responsible for the early phase of engraftment. 12, 21 Soon after PBSCT, a monocytosis peak was observed which might be attributed to a stimulation of myelopoiesis by G-CSF given after PBSCT. On the other hand, this phenomenon might also result from transfused monocytes contaminating the stem cell graft. 16 The recovery of lymphocyte subsets differs for B, T and NK cells, reflecting different pathways used by lineage-committed precursors to mature into various terminally differentiated cells during their developmental progression. [22] [23] [24] Interestingly, in our study the NK cells increased rapidly in the first month, up to one-third of all lymphocytes reconstituted at that time, and returned to normal values after 1 year. These data concur with those previously published by Kook et al, 25 who hypothetised that the origin of the sudden early NK cell peak was NK cells transfused within the inocculum or generated from more mature precursors.
Significantly, an impaired reconstitution of B lymphopoiesis was detected, which might be due to a delayed proliferation and prolonged differentiation to pre-B cells and mature B cells. 24, 25 Furthermore, the bone marrow microenvironment might be altered by HDC, affecting the homing of the specific subpopulations caused by defects of the cellto-cell contact and insufficient cytokine support. 26 A primary increase of CD3 + CD8 + cytotoxic T lymphocytes could be detected, whereas the CD3 + CD4 + helper/inducer T cells remained depressed throughout the study period. 16, [22] [23] [24] [25] The early engraftment might more likely be attributed to the transfusion of T cells whose lifespan in the recipient is not well known. 27 In addition, the survival of endogenous T lymphocytes in spite of HDC could not be ruled out. Nevertheless, the life-long reconstitution of the cellular immune system needs the generation of T lymphocytes from HSCs. After HDC the thymus is severely damaged, with a decline in the capacity of maturation of thymocytes caused by an age-dependent involution of the thymus. The lack of sustained regeneration of CD3 + CD4 + T lymphocytes suggests a thymus-dependent pathway. [28] [29] [30] [31] In this context, Heitger et al 31 show that residual thymus function is essential for the regeneration of the naive T helper cells (CD4 + CD45RA + ). In our study the CD3+CD8+ T-lymphocytes, mainly of CD45RO+ phenotype, engrafted promptly. There is increasing evidence for the existence of an extrathymic maturation pathway in animals with no difference between thymectomized and thymus-bearing mice. Hakim et al showed a protracted CD4
+ cell recovery with a low CD45CD4 + RA + regeneration suggesting that thymic production is not the main route for CD4 + regeneration. 32, 33 While we and other groups 25, [28] [29] [30] [31] evaluated T lymphocyte subsets after PBSCT, little is known about the functional capacity of their subsets. Whereas the coexpression of the IL2 receptor ␣-chain (CD25) on CD3
+ lymphocytes remained at a low level, we observed a marked increase of HLA-DR molecules on their surface which might be explained by the chemotherapyinduced susceptibility to apoptosis in T cells. 33 Furthermore, we investigated the intracellular de novo production of various cytokines in cytotoxic as well as in helper T cell subsets after in vitro stimulation. Although the in vitro stimulation does not fully reflect the in vivo situation, results could serve as a surrogate for the functional capacity of the producer. Early after PBSCT, the production of IFN␥ by CD3 + T lymphocytes was significantly depressed compared to controls,but increased to near-normal values 12 months after PBSCT with a higher MFI shift indicating more pronounced cytokine production per single cell. The IL-2 synthesis in patients after PBSCT appeared to be comparable to those of healthy volunteers whereas the TNF␣ production was increased in T lymphocytes of the transplanted patient cohort. Taken together, both the impaired regeneration of CD3 + CD4 + T cells and the poor IFN␥ production suggest a functionally limited immune system, which is in line with the clinical observation that viral and fungal infections are occasional events after PBSCT.
In conclusion, besides a complete hematopoietic reconstitution, the regeneration of the cellular immune system is partly impaired. B lymphocytes are not detectable in the first month post PBSCT but are restored completely after 3 months. Only the CD3 + CD4 + helper/inducer T lymphocytes do not regenerate sufficiently thoughout the study period, indicating an impaired thymus-dependent pathway. The analysis of intracellular cytokines in T cell subsets suggests the functional integrity of T cells with the exception of CD3 + CD4 + T cells particularly for IFN␥ production.
